These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10404699)
21. Enhanced major histocompatibility complex (MHC) class II antigen expression in lupus nephritis. Cheah PL; Looi LM; Chua CT; Yap SF; Fleming S Malays J Pathol; 1997 Dec; 19(2):115-20. PubMed ID: 10879251 [TBL] [Abstract][Full Text] [Related]
22. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related]
23. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis]. Haake H; Köneke J; Amann K; vom Dahl J; Janssen U Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969 [TBL] [Abstract][Full Text] [Related]
24. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590 [TBL] [Abstract][Full Text] [Related]
25. [Immunonegative necrotizing glomerulonephritis: an atypical case of lupus nephropathy]. Coll E; Vallès M; Torguet P; Bronsoms J; Maté G; Bernadó L; Mauri JM Nefrologia; 2003; 23(1):81-4. PubMed ID: 12708380 [TBL] [Abstract][Full Text] [Related]
26. Class V lupus nephritis: a clinicopathologic study in 152 patients. Chen Q; Liu Z; Hu W; Chen H; Zeng C; Li L J Nephrol; 2003; 16(1):126-32. PubMed ID: 12653107 [TBL] [Abstract][Full Text] [Related]
27. [C1q nephropathy. Report of one case]. Panuncio A; Alba A; Bacigalupe C; Caorsi H; Schwedt E; Otatti G; Saralegui P; Mariño A Rev Med Chil; 2008 Oct; 136(10):1307-10. PubMed ID: 19194628 [TBL] [Abstract][Full Text] [Related]
28. [Lupus nephritis in children and adolescents: clinical and morphologic aspects and clinico-morphologic correlations]. Bogdanović R; Nikolić V; Ognjanović M; Dimitrijević J; Marković-Lipkovski J; Pasić S; Minić A; Stajić N Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():1-5. PubMed ID: 12583306 [TBL] [Abstract][Full Text] [Related]
30. SDS-PAGE patterns and polymeric albumin in proteinuria of lupus glomerulonephritis. Bazzi C; Petrini C; Rizza V; Sabadini E; Arrigo G; Beltrame A; D'Amico G Clin Nephrol; 1995 Feb; 43(2):96-103. PubMed ID: 7736685 [TBL] [Abstract][Full Text] [Related]
31. The clinical relevance of a repeat biopsy in lupus nephritis flares. Daleboudt GM; Bajema IM; Goemaere NN; van Laar JM; Bruijn JA; Berger SP Nephrol Dial Transplant; 2009 Dec; 24(12):3712-7. PubMed ID: 19622571 [TBL] [Abstract][Full Text] [Related]
32. Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications. Adler SG; Johnson K; Louie JS; Liebling MR; Cohen AH Mod Pathol; 1990 Mar; 3(2):186-91. PubMed ID: 2326250 [TBL] [Abstract][Full Text] [Related]
33. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus. Mak A; Cheung BM; Mok CC; Leung R; Lau CS Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522 [TBL] [Abstract][Full Text] [Related]
34. Significance of antinuclear antibody (ANA) immunofluorescent patterns and titers in systemic lupus erythematosus nephritis. Akbar S; Tello AI; Luvira U; Heinzerling R; Romanski R; Levin NW; Burnham TK Henry Ford Hosp Med J; 1988; 36(2):121-9. PubMed ID: 3068209 [No Abstract] [Full Text] [Related]
35. A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset. Yamada T; Itagaki F; Aratani S; Kawasaki S; Terada K; Mugishima K; Kashiwagi T; Shimizu A; Tsuruoka S CEN Case Rep; 2019 Nov; 8(4):301-307. PubMed ID: 31399881 [TBL] [Abstract][Full Text] [Related]
36. Changes in pathological pattern and treatment regimens based on repeat renal biopsy in lupus nephritis. Wang GB; Xu ZJ; Liu HF; Zhou QG; Zhou ZM; Jia N Chin Med J (Engl); 2012 Aug; 125(16):2890-4. PubMed ID: 22932086 [TBL] [Abstract][Full Text] [Related]
37. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [TBL] [Abstract][Full Text] [Related]
38. Pauci-immune lupus nephritis: a case report. Li FC; Hwang DY; Hung CC; Chen HC Kaohsiung J Med Sci; 2008 Oct; 24(10):531-5. PubMed ID: 19181584 [TBL] [Abstract][Full Text] [Related]
39. A clinico-pathological study on progress factors in lupus nephritis. Sasagawa Y Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):399-410. PubMed ID: 8341020 [TBL] [Abstract][Full Text] [Related]
40. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]